These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33116411)

  • 1. Dexmedetomidine Attenuates Cellular Injury and Apoptosis in H9c2 Cardiomyocytes by Regulating p-38MAPK and Endoplasmic Reticulum Stress.
    Zhu Z; Ling X; Zhou H; Zhang C; Yan W
    Drug Des Devel Ther; 2020; 14():4231-4243. PubMed ID: 33116411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine Attenuates Hypoxia/Reoxygenation Injury of H9C2 Myocardial Cells by Upregulating miR-146a Expression via the MAPK Signal Pathway.
    Chu Y; Teng J; Feng P; Liu H; Wang F; Wang H
    Pharmacology; 2022; 107(1-2):14-27. PubMed ID: 34718238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexmedetomidine reversed hypoxia/reoxygenation injury-induced oxidative stress and endoplasmic reticulum stress-dependent apoptosis of cardiomyocytes via SIRT1/CHOP signaling pathway.
    Zhang Y; Zhao Q; Li X; Ji F
    Mol Cell Biochem; 2021 Jul; 476(7):2803-2812. PubMed ID: 33725228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine at a dose of 1 µM attenuates H9c2 cardiomyocyte injury under 3 h of hypoxia exposure and 3 h of reoxygenation through the inhibition of endoplasmic reticulum stress.
    Zhu Z; Ling X; Zhou H; Zhang C
    Exp Ther Med; 2021 Feb; 21(2):132. PubMed ID: 33376514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of dexmedetomidine on hypoxia/reoxygenation injury in cardiomyocytes by regulating the CHOP signaling pathway.
    Shi X; Liu Z; Li J
    Mol Med Rep; 2020 Oct; 22(4):3307-3315. PubMed ID: 32945482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetes Mellitus by Inhibiting Endoplasmic Reticulum Stress.
    Li J; Zhao Y; Zhou N; Li L; Li K
    J Diabetes Res; 2019; 2019():7869318. PubMed ID: 31886285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective effect of lycopene on hypoxia/reoxygenation-induced endoplasmic reticulum stress in H9C2 cardiomyocytes.
    Gao Y; Jia P; Shu W; Jia D
    Eur J Pharmacol; 2016 Mar; 774():71-9. PubMed ID: 26845695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine attenuates neuronal injury after spinal cord ischaemia-reperfusion injury by targeting the CNPY2-endoplasmic reticulum stress signalling.
    Zhao L; Zhai M; Yang X; Guo H; Cao Y; Wang D; Li P; Liu C
    J Cell Mol Med; 2019 Dec; 23(12):8173-8183. PubMed ID: 31625681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling.
    Yuan M; Meng XW; Ma J; Liu H; Song SY; Chen QC; Liu HY; Zhang J; Song N; Ji FH; Peng K
    Drug Des Devel Ther; 2019; 13():3137-3149. PubMed ID: 31564830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine attenuates hepatic ischemia-reperfusion injury-induced apoptosis via reducing oxidative stress and endoplasmic reticulum stress.
    Zhang S; Tang J; Sun C; Zhang N; Ning X; Li X; Wang J
    Int Immunopharmacol; 2023 Apr; 117():109959. PubMed ID: 36881980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxic preconditioning protects microvascular endothelial cells against hypoxia/reoxygenation injury by attenuating endoplasmic reticulum stress.
    Wu XD; Zhang ZY; Sun S; Li YZ; Wang XR; Zhu XQ; Li WH; Liu XH
    Apoptosis; 2013 Jan; 18(1):85-98. PubMed ID: 23108759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-1 attenuates endoplasmic reticulum stress-induced apoptosis in H9c2 cardiomyocytes during hypoxia/reoxygenation through the GLP-1R/PI3K/Akt pathways.
    Guan G; Zhang J; Liu S; Huang W; Gong Y; Gu X
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):715-722. PubMed ID: 30762075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cFLIP
    Li YZ; Wu H; Liu D; Yang J; Yang J; Ding JW; Zhou G; Zhang J; Zhang D
    Cardiovasc Drugs Ther; 2023 Apr; 37(2):225-238. PubMed ID: 34767133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine protects cardiomyocytes against hypoxia/reoxygenation injury via multiple mechanisms.
    Cai S; Liu Y; Cheng Y; Yuan J; Fang J
    J Clin Lab Anal; 2022 Jul; 36(7):e24119. PubMed ID: 34882841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine attenuates ischemia and reperfusion-induced cardiomyocyte injury through p53 and forkhead box O3a (FOXO3a)/p53-upregulated modulator of apoptosis (PUMA) signaling signaling.
    Yang FY; Zhang L; Zheng Y; Dong H
    Bioengineered; 2022 Jan; 13(1):1377-1387. PubMed ID: 34974801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide attenuates endoplasmic reticulum stress in H9c2 cardiomyocytes underwent hypoxia/reoxygenation injury under high glucose/high fat conditions.
    Chang P; Zhang M; Zhang X; Li G; Hu H; Wu J; Wang X; Yang Z; Zhang J; Chen W; Ren M; Li X; Zhu M; Chen B; Yu J
    Peptides; 2019 Jan; 111():103-111. PubMed ID: 29689346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting (pro)renin receptor-mediated p38 MAPK signaling decreases hypoxia/reoxygenation-induced apoptosis in H9c2 cells.
    Liu Y; Zhang S; Su D; Liu J; Cheng Y; Zou L; Li W; Jiang Y
    Mol Cell Biochem; 2015 May; 403(1-2):267-76. PubMed ID: 25711402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin attenuates hypoxia/reoxygenation‑induced myocardial injury.
    Wei W; Peng J; Li J
    Mol Med Rep; 2019 Dec; 20(6):4821-4830. PubMed ID: 31638219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis Is Involved in Diabetes Myocardial Ischemia/Reperfusion Injury Through Endoplasmic Reticulum Stress.
    Li W; Li W; Leng Y; Xiong Y; Xia Z
    DNA Cell Biol; 2020 Feb; 39(2):210-225. PubMed ID: 31809190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine protects against oxygen-glucose deprivation/reoxygenation injury-induced apoptosis via the p38 MAPK/ERK signalling pathway.
    Wang K; Zhu Y
    J Int Med Res; 2018 Feb; 46(2):675-686. PubMed ID: 29210287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.